Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
303.06
+2.18 (0.72%)
At close: Nov 9, 2026, 4:00 PM EST
306.55
+3.49 (1.15%)
Pre-market: Nov 10, 2026, 7:10 AM EST
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $8.98 billion as of November 9, 2026. It is the 2,323rd most valuable company in the world and the 822nd biggest in the United States. Its market cap has increased by 56.47% in one year.
Market Cap
8.98B
Enterprise Value
7.80B
1-Year Change
56.47%
Global Rank
Country Rank
#822 United States
Category
ChartMarket Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $8.98B, an increase of 9,619.39%. That is a compound annual growth rate of 64.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 8.98B | 25.62% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxcyte | 10.11B |
| Spyre Therapeutics | 9.86B |
| Madrigal Pharmaceuticals | 9.28B |
| ImmunityBio | 9.15B |
| Protagonist Therapeutics | 8.54B |
| TG Therapeutics | 8.49B |
| Arrowhead Pharmaceuticals | 8.22B |
| Corcept Therapeutics | 7.96B |